Journal
ESC HEART FAILURE
Volume 10, Issue 4, Pages 2479-2486Publisher
WILEY PERIODICALS, INC
DOI: 10.1002/ehf2.14417
Keywords
Danon disease; LAMP2; Splicing mutation; Genetic diagnosis; Minigene assay
Categories
Ask authors/readers for more resources
This study aimed to identify a novel splice-altering LAMP2 variant associated with Danon disease. Whole-exome sequencing and Sanger sequencing were conducted to identify the potential genetic mutation in a Chinese pedigree. A splice-site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified as a potential pathogenic variant. The results revealed a truncated protein and conformational abnormality caused by this variant, expanding the LAMP2 variant spectrum and contributing to the diagnosis of Danon disease.
AimsThis study aimed to identify a novel splicing-altering LAMP2 variant associated with Danon disease. Methods and resultsTo identify the potential genetic mutation in a Chinese pedigree, whole-exome sequencing was conducted in the proband, and Sanger sequencing was performed on the proband's parents. To verify the impact of the splice-site variant, a minigene splicing assay was applied. The AlphaFold2 analysis was used to analyse the mutant protein structure. A splice-site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified as a potential pathogenic variant. The minigene splicing revealed that this variant causes exon 6 to be skipped, resulting in a truncated protein. The AlphaFold2 analysis showed that the mutation caused a protein twist direction change, leading to conformational abnormality. ConclusionsA novel splice-site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified. This discovery may enlarge the LAMP2 variant spectrum, promote accurate genetic counselling, and contribute to the diagnosis of Danon disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available